foxo4-dri peptide mechanism of action Molecular modelling the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells FOXO4 - an overview |
FOXO4 an overview ScienceDirect Topics FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI Simple Peptide Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv
Pay in 4 interest-free payments of $7.13 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




